John A. Roberts

Insider Reports History

Entity
Individual
Location
C/O Cancer Genetics, Inc., 201 Route 17 North, 2 Nd Floor, Rutherford, NJ
Signature
/s/ Shane J. Schaffer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John A. Roberts:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vyant Bio, Inc. Chief Executive Officer, Director Stock option (right to buy) 150K Mar 15, 2022 Direct
Cingulate Inc. Director Stock Option (right to Buy) 10K Jun 12, 2024 Direct

Insider Reports Filed by John A. Roberts

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CING Cingulate Inc. Jun 11, 2024 3 $0 4 Jun 13, 2024 Director
CING Cingulate Inc. Mar 4, 2024 1 $0 4 Mar 6, 2024 Director
CING Cingulate Inc. Feb 12, 2024 0 $0 3 Feb 14, 2024 Director
VYNT Vyant Bio, Inc. Mar 15, 2022 1 $0 4 Mar 17, 2022 Chief Executive Officer, Director
VYNT Vyant Bio, Inc. Nov 24, 2021 1 $10.1K 4 Nov 24, 2021 Chief Executive Officer
VYNT Vyant Bio, Inc. Aug 23, 2021 1 $25.1K 4 Aug 25, 2021 Chief Executive Officer
VYNT Vyant Bio, Inc. May 24, 2021 0 $0 4/A Aug 25, 2021 Chief Executive Officer